| Year |
Citation |
Score |
| 2022 |
Lecointre C, Fourgous E, Montarras I, Kerneur C, Simon V, Boublik Y, Bonenfant D, Robert B, Martineau P, Roche S. Oncogenic Signalling of PEAK2 Pseudokinase in Colon Cancer. Cancers. 14. PMID 35740644 DOI: 10.3390/cancers14122981 |
0.481 |
|
| 2022 |
Aponte E, Lafitte M, Sirvent A, Simon V, Barbery M, Fourgous E, Boublik Y, Maffei M, Armand F, Hamelin R, Pannequin J, Fort P, Pons M, Roche S. Regulation of Src tumor activity by its N-terminal intrinsically disordered region. Oncogene. 41: 960-970. PMID 34999732 DOI: 10.1038/s41388-021-02092-x |
0.452 |
|
| 2021 |
Ounoughene Y, Fourgous E, Boublik Y, Saland E, Guiraud N, Recher C, Urbach S, Fort P, Sarry JE, Fesquet D, Roche S. SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase. Cancers. 13. PMID 34944965 DOI: 10.3390/cancers13246344 |
0.465 |
|
| 2020 |
Sirvent A, Mevizou R, Naim D, Lafitte M, Roche S. Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis. Cancers. 12. PMID 32717909 DOI: 10.3390/Cancers12082014 |
0.588 |
|
| 2020 |
Lafitte M, Sirvent A, Roche S. Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer. Frontiers in Oncology. 10: 125. PMID 32117772 DOI: 10.3389/Fonc.2020.00125 |
0.417 |
|
| 2019 |
Lafitte M, Lecointre C, Roche S. Roles of exosomes in metastatic colon cancer. American Journal of Physiology. Cell Physiology. PMID 31291143 DOI: 10.1152/Ajpcell.00218.2019 |
0.402 |
|
| 2019 |
Mevizou R, Sirvent A, Roche S. Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer. Cancers. 11. PMID 31091767 DOI: 10.3390/Cancers11050669 |
0.558 |
|
| 2019 |
Roche S, Lecointre C, Simon V, Labesse G. SHEDding light on the role of Pragmin pseudo-kinases in cancer. American Journal of Cancer Research. 9: 449-454. PMID 30906642 |
0.455 |
|
| 2018 |
Lecointre C, Simon V, Kerneur C, Allemand F, Fournet A, Montarras I, Pons JL, Gelin M, Brignatz C, Urbach S, Labesse G, Roche S. Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation. Structure (London, England : 1993). 26: 1563. PMID 30403993 DOI: 10.1016/j.str.2018.10.020 |
0.416 |
|
| 2018 |
Sirvent A, Lafitte M, Roche S. DDR1 inhibition as a new therapeutic strategy for colorectal cancer. Molecular & Cellular Oncology. 5: e1465882. PMID 30250919 DOI: 10.1080/23723556.2018.1465882 |
0.554 |
|
| 2018 |
Lecointre C, Simon V, Kerneur C, Allemand F, Fournet A, Montarras I, Pons JL, Gelin M, Brignatz C, Urbach S, Labesse G, Roche S. Dimerization of the Pragmin Pseudo-Kinase Regulates Protein Tyrosine Phosphorylation. Structure (London, England : 1993). PMID 29503074 DOI: 10.1016/J.Str.2018.01.017 |
0.543 |
|
| 2018 |
Jeitany M, Leroy C, Tosti P, Lafitte M, Le Guet J, Simon V, Bonenfant D, Robert B, Grillet F, Mollevi C, El Messaoudi S, Otandault A, Canterel-Thouennon L, Busson M, Thierry AR, ... ... Roche S, et al. Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. Embo Molecular Medicine. PMID 29438985 DOI: 10.15252/Emmm.201707918 |
0.834 |
|
| 2017 |
Imjeti NS, Menck K, Egea-Jimenez AL, Lecointre C, Lembo F, Bouguenina H, Badache A, Ghossoub R, David G, Roche S, Zimmermann P. Syntenin mediates SRC function in exosomal cell-to-cell communication. Proceedings of the National Academy of Sciences of the United States of America. PMID 29109268 DOI: 10.1073/Pnas.1713433114 |
0.492 |
|
| 2017 |
Arbesú M, Maffei M, Cordeiro TN, Teixeira JM, Pérez Y, Bernadó P, Roche S, Pons M. The Unique Domain Forms a Fuzzy Intramolecular Complex in Src Family Kinases. Structure (London, England : 1993). PMID 28319009 DOI: 10.1016/J.Str.2017.02.011 |
0.326 |
|
| 2016 |
Chevalier C, Roche S, Bénistant C. Vesicular trafficking regulators are new players in breast cancer progression: Role of TOM1L1 in ERBB2-dependent invasion. Molecular & Cellular Oncology. 3: e1182241. PMID 27652326 DOI: 10.1080/23723556.2016.1182241 |
0.357 |
|
| 2016 |
Chevalier C, Collin G, Descamps S, Touaitahuata H, Simon V, Reymond N, Fernandez L, Milhiet PE, Georget V, Urbach S, Lasorsa L, Orsetti B, Boissière-Michot F, Lopez-Crapez E, Theillet C, ... Roche S, et al. TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion. Nature Communications. 7: 10765. PMID 26899482 DOI: 10.1038/Ncomms10765 |
0.797 |
|
| 2016 |
Naudin C, Chevalier C, Roche S. The role of small adaptor proteins in the control of oncogenic signalingr driven by tyrosine kinases in human cancer. Oncotarget. 7: 11033-55. PMID 26788993 DOI: 10.18632/Oncotarget.6929 |
0.75 |
|
| 2016 |
Tosti P, Leroy C, Jeitany M, Simon V, Bonenfant D, Thouennon L, Elmessaoudi S, Mollevi C, Thierry A, Martineau P, Robert B, Sirvent A, Roche S. The anti-leukemic drug nilotinib inhibits metastatic properties of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1 European Journal of Cancer. 61: S148-S149. DOI: 10.1016/S0959-8049(16)61524-1 |
0.779 |
|
| 2015 |
Dubois F, Leroy C, Simon V, Benistant C, Roche S. YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells. American Journal of Cancer Research. 5: 1972-87. PMID 26269757 |
0.789 |
|
| 2015 |
Gioia R, Trégoat C, Dumas PY, Lagarde V, Prouzet-Mauléon V, Desplat V, Sirvent A, Praloran V, Lippert E, Villacreces A, Leconet W, Robert B, Vigon I, Roche S, Mahon FX, et al. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia. The Journal of Pathology. 237: 14-24. PMID 25965880 DOI: 10.1002/Path.4561 |
0.502 |
|
| 2015 |
Chevalier C, Cannet A, Descamps S, Sirvent A, Simon V, Roche S, Benistant C. ABL tyrosine kinase inhibition variable effects on the invasive properties of different triple negative breast cancer cell lines. Plos One. 10: e0118854. PMID 25803821 DOI: 10.1371/Journal.Pone.0118854 |
0.497 |
|
| 2015 |
Sirvent A, Urbach S, Roche S. Contribution of phosphoproteomics in understanding SRC signaling in normal and tumor cells. Proteomics. 15: 232-44. PMID 25403792 DOI: 10.1002/Pmic.201400162 |
0.539 |
|
| 2015 |
Fénié N, Bertrand C, Lacombe A, Roche S, Bousquet C, Gouazé-Andersson V, Toulas C, Moyal E, Ferrand A. Abstract B16: Progastrin activates colon fibroblasts and participates to the dialogue between tumor epithelial cells and stromal fibroblasts in colorectal cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-B16 |
0.453 |
|
| 2015 |
Gioia R, Trégoat C, Dumas PY, Lagarde V, Prouzet-Mauléon V, Desplat V, Sirvent A, Praloran V, Lippert E, Villacreces A, Leconet W, Robert B, Vigon I, Roche S, Mahon FX, et al. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia Journal of Pathology. DOI: 10.1002/path.4561 |
0.301 |
|
| 2014 |
Najib S, Kowalski-Chauvel A, Do C, Roche S, Cohen-Jonathan-Moyal E, Seva C. Progastrin a new pro-angiogenic factor in colorectal cancer. Oncogene. 34: 3120-30. PMID 25109333 DOI: 10.1038/Onc.2014.255 |
0.415 |
|
| 2014 |
Sirvent A, Urbach S, Roche S. [Analysis of oncogenic signaling induced by tyrosine kinases in tumors by SILAC-based quantitative proteomic approach]. Medecine Sciences : M/S. 30: 558-66. PMID 24939544 DOI: 10.1051/Medsci/20143005020 |
0.517 |
|
| 2014 |
David M, Naudin C, Letourneur M, Polrot M, Renoir JM, Lazar V, Dessen P, Roche S, Bertoglio J, Pierre J. Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells. Molecular Oncology. 8: 942-55. PMID 24726456 DOI: 10.1016/J.Molonc.2014.03.014 |
0.72 |
|
| 2014 |
Naudin C, Sirvent A, Leroy C, Larive R, Simon V, Pannequin J, Bourgaux JF, Pierre J, Robert B, Hollande F, Roche S. SLAP displays tumour suppressor functions in colorectal cancer via destabilization of the SRC substrate EPHA2. Nature Communications. 5: 3159. PMID 24457997 DOI: 10.1038/Ncomms4159 |
0.848 |
|
| 2013 |
Tosti P, Leroy C, Simon V, Robert B, Pierre J, Sirvent A, Roche S. Abstract 2085: The antileukemic drug nilotinib inhibits the invasive activity and the metastatic potential of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1. Cancer Research. 73: 2085-2085. DOI: 10.1158/1538-7445.Am2013-2085 |
0.823 |
|
| 2012 |
Sirvent A, Vigy O, Orsetti B, Urbach S, Roche S. Analysis of SRC oncogenic signaling in colorectal cancer by stable isotope labeling with heavy amino acids in mouse xenografts. Molecular & Cellular Proteomics : McP. 11: 1937-50. PMID 23023324 DOI: 10.1074/Mcp.M112.018168 |
0.521 |
|
| 2012 |
Fialin C, Larrue C, Vergez F, Sarry JE, Bertoli S, Mansat-De Mas V, Demur C, Delabesse E, Payrastre B, Manenti S, Roche S, Récher C. The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors. Leukemia. 27: 325-35. PMID 22902361 DOI: 10.1038/Leu.2012.240 |
0.832 |
|
| 2012 |
Sirvent A, Benistant C, Roche S. Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer. American Journal of Cancer Research. 2: 357-71. PMID 22860228 |
0.436 |
|
| 2012 |
Tregoat C, Gioia R, Lagarde V, Prouzet-Mauleon V, Lippert E, Sirvent A, Roche S, Mahon F, Pasquet J. Cbl Controls the Expression of Axl and Lyn Tyrosine Kinases Mediating Resistance to Nilotinib in Chronic Myeloid Leukemia Cells Blood. 120: 3734-3734. DOI: 10.1182/Blood.V120.21.3734.3734 |
0.47 |
|
| 2012 |
Leroy C, Tosti P, Simon V, Robert B, Sirvent A, Roche S. Abstract 855: The antileukemia drug nilotinib inhibits invasion and metastasis of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1 Cancer Research. 72: 855-855. DOI: 10.1158/1538-7445.Am2012-855 |
0.815 |
|
| 2012 |
Sirvent A, Urbach S, Roche S. Abstract 230: A novel quantitative phosphoproteomic approach in mouse xenograft models to identify Src oncogenic signaling in colorectal cancer Cancer Research. 72: 230-230. DOI: 10.1158/1538-7445.Am2012-230 |
0.521 |
|
| 2011 |
Gioia R, Leroy C, Drullion C, Lagarde V, Etienne G, Dulucq S, Lippert E, Roche S, Mahon FX, Pasquet JM. Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells Blood. 118: 2211-2221. PMID 21730355 DOI: 10.1182/Blood-2010-10-313692 |
0.804 |
|
| 2011 |
Sancier F, Dumont A, Sirvent A, Paquay de Plater L, Edmonds T, David G, Jan M, de Montrion C, Cogé F, Léonce S, Burbridge M, Bruno A, Boutin JA, Lockhart B, Roche S, et al. Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells. Plos One. 6: e17237. PMID 21390316 DOI: 10.1371/Journal.Pone.0017237 |
0.511 |
|
| 2011 |
Fialin C, Vergez F, Bertoli S, Mas VM, Demur C, Delabesse E, Payrastre B, Manenti S, Roche S, Récher C. Abstract 3130: The short form of the receptor tyrosine kinase Ron is expressed in acute myeloid leukemia, regulated by methylation and sensitizes leukemic cells to c-Met inhibitors Cancer Research. 71: 3130-3130. DOI: 10.1158/1538-7445.Am2011-3130 |
0.84 |
|
| 2011 |
Naudin C, Leroy C, Sirvent A, Simon V, Bourgaux J, Robert B, Pannequin J, Hollande F, Roche S. Abstract 1981: Tumor suppressor functions of the Src-like adaptor protein (SLAP) in colorectal cancer cells Cancer Research. 71: 1981-1981. DOI: 10.1158/1538-7445.Am2011-1981 |
0.842 |
|
| 2010 |
García-Martínez JM, Calcabrini A, González L, Martín-Forero E, Agulló-Ortuño MT, Simon V, Watkin H, Anderson SM, Roche S, Martín-Pérez J. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling. Cellular Signalling. 22: 415-26. PMID 19892015 DOI: 10.1016/J.Cellsig.2009.10.013 |
0.575 |
|
| 2010 |
Gioia R, Leroy C, Drullion C, Lagarde V, Roche S, Mahon F, Pasquet j. Quantitative Phosphoproteomics Identified a New Syk-Lyn-Axl Signalling Pathway Involved In Resistance to Nilotinib In Chronic Myeloid Leukemia Cells. Blood. 116: 3376-3376. DOI: 10.1182/Blood.V116.21.3376.3376 |
0.788 |
|
| 2010 |
Leroy C, Robert B, Simon V, Roche S. 442 The Abl tyrosine kinase inhibitor Nilotinib inhibits invasive properties of colon cancer cells by targeting the discoidin domain receptor 1 European Journal of Cancer Supplements. 8: 113. DOI: 10.1016/S1359-6349(10)71243-X |
0.791 |
|
| 2010 |
Naudin C, Leroy C, Sirvent A, Simon V, Bourgaux J, Robert B, Hollande F, Roche S. R37: Activité anti-oncogénique de la protéine de signalisation Src-Like Adaptor Protein dans les cancers colorectaux Bulletin Du Cancer. 97: S30. DOI: 10.1016/S0007-4551(15)30954-1 |
0.658 |
|
| 2010 |
Fialin C, Vergez F, Reutenauer S, Mansat-De Mas V, Demur C, Delabesse E, Payrastre B, Manenti S, Roche S, Récher C. R18: Expression, rôle et régulation épigénétique de la forme courte de Ron dans les leucémies aiguës myéloïdes (LAM) Bulletin Du Cancer. 97: S23. DOI: 10.1016/S0007-4551(15)30935-8 |
0.744 |
|
| 2009 |
Sirvent A, Bénistant C, Pannequin J, Veracini L, Simon V, Bourgaux JF, Hollande F, Cruzalegui F, Roche S. Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization. Oncogene. 29: 1303-15. PMID 20010872 DOI: 10.1038/Onc.2009.450 |
0.585 |
|
| 2009 |
Brignatz C, Paronetto MP, Opi S, Cappellari M, Audebert S, Feuillet V, Bismuth G, Roche S, Arold ST, Sette C, Collette Y. Alternative splicing modulates autoinhibition and SH3 accessibility in the Src kinase Fyn. Molecular and Cellular Biology. 29: 6438-48. PMID 19805512 DOI: 10.1128/Mcb.00398-09 |
0.539 |
|
| 2009 |
Leroy C, Fialin C, Sirvent A, Simon V, Urbach S, Poncet J, Robert B, Jouin P, Roche S. Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells. Cancer Research. 69: 2279-86. PMID 19276381 DOI: 10.1158/0008-5472.Can-08-2354 |
0.841 |
|
| 2009 |
Fialin C, De Mas V, Manenti S, Payrastre B, Roche S, Recher C. The Receptor Tyrosine Kinase RON Is Constitutively Activated in Acute Myeloid Leukemia and May Represent a New Therapeutic Target. Blood. 114: 994-994. DOI: 10.1182/Blood.V114.22.994.994 |
0.848 |
|
| 2009 |
Pasquet J, Gioia R, Drullion C, Lagarde V, Leroy C, Roche S, Cardinaud B, Mahon F. Tyrosine Kinase Proteins profiling of Nilotinib Resistant Chronic Myelogenous Leukemia Cells Unravels a Tyrosine Kinase-Mediated Bypass. Blood. 114: 2175-2175. DOI: 10.1182/Blood.V114.22.2175.2175 |
0.81 |
|
| 2008 |
Mahon FX, Hayette S, Lagarde V, Belloc F, Turcq B, Nicolini F, Belanger C, Manley PW, Leroy C, Etienne G, Roche S, Pasquet JM. Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. Cancer Research. 68: 9809-16. PMID 19047160 DOI: 10.1158/0008-5472.Can-08-1008 |
0.782 |
|
| 2008 |
Sirvent A, Benistant C, Roche S. Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells. Biology of the Cell. 100: 617-31. PMID 18851712 DOI: 10.1042/Bc20080020 |
0.537 |
|
| 2008 |
Veracini L, Simon V, Richard V, Schraven B, Horejsi V, Roche S, Benistant C. The Csk-binding protein PAG regulates PDGF-induced Src mitogenic signaling via GM1. The Journal of Cell Biology. 182: 603-14. PMID 18695048 DOI: 10.1083/Jcb.200705102 |
0.52 |
|
| 2008 |
Sirvent A, Leroy C, Boureux A, Simon V, Roche S. The Src-like adaptor protein regulates PDGF-induced actin dorsal ruffles in a c-Cbl-dependent manner. Oncogene. 27: 3494-500. PMID 18193084 DOI: 10.1038/Sj.Onc.1211011 |
0.792 |
|
| 2008 |
Mahon Fe, Hayette S, Lagarde V, Nicolini FE, Belloc F, Leroy C, Roche S, Manley P, Belanger C, Etienne G, Pasquet J. Lyn Kinase Overexpression Is One of the Mechanisms of Resistance to Nilotinib In Chronic Myeloid Leukemia Blood. 112: 3181-3181. DOI: 10.1182/Blood.V112.11.3181.3181 |
0.777 |
|
| 2007 |
Collin G, Franco M, Simon V, Bénistant C, Roche S. The Tom1L1-clathrin heavy chain complex regulates membrane partitioning of the tyrosine kinase Src required for mitogenic and transforming activities. Molecular and Cellular Biology. 27: 7631-40. PMID 17785434 DOI: 10.1128/Mcb.00543-07 |
0.82 |
|
| 2007 |
Sirvent A, Boureux A, Simon V, Leroy C, Roche S. The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells. Oncogene. 26: 7313-23. PMID 17533370 DOI: 10.1038/Sj.Onc.1210543 |
0.817 |
|
| 2006 |
Veracini L, Franco M, Boureux A, Simon V, Roche S, Benistant C. Two distinct pools of Src family tyrosine kinases regulate PDGF-induced DNA synthesis and actin dorsal ruffles. Journal of Cell Science. 119: 2921-34. PMID 16787943 DOI: 10.1242/Jcs.03015 |
0.815 |
|
| 2006 |
Franco M, Furstoss O, Simon V, Benistant C, Hong WJ, Roche S. The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors. Molecular and Cellular Biology. 26: 1932-47. PMID 16479011 DOI: 10.1128/Mcb.26.5.1932-1947.2006 |
0.812 |
|
| 2005 |
Boureux A, Furstoss O, Simon V, Roche S. Abl tyrosine kinase regulates a Rac/JNK and a Rac/Nox pathway for DNA synthesis and Myc expression induced by growth factors. Journal of Cell Science. 118: 3717-26. PMID 16076903 DOI: 10.1242/Jcs.02491 |
0.848 |
|
| 2005 |
Veracini L, Franco M, Boureux A, Simon V, Roche S, Benistant C. Two functionally distinct pools of Src kinases for PDGF receptor signalling Biochemical Society Transactions. 33: 1313-1315. DOI: 10.1042/Bst0331313 |
0.8 |
|
| 2004 |
Cussac D, Greenland C, Roche S, Bai RY, Duyster J, Morris SW, Delsol G, Allouche M, Payrastre B. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Blood. 103: 1464-71. PMID 14563642 DOI: 10.1182/Blood-2003-04-1038 |
0.577 |
|
| 2003 |
Hollande F, Lee DJ, Choquet A, Roche S, Baldwin GS. Adherens junctions and tight junctions are regulated via different pathways by progastrin in epithelial cells. Journal of Cell Science. 116: 1187-97. PMID 12615962 DOI: 10.1242/Jcs.00321 |
0.562 |
|
| 2003 |
Piiper A, Elez R, You SJ, Kronenberger B, Loitsch S, Roche S, Zeuzem S. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon. The Journal of Biological Chemistry. 278: 7065-72. PMID 12496267 DOI: 10.1074/Jbc.M211234200 |
0.562 |
|
| 2002 |
Pandey A, Blagoev B, Kratchmarova I, Fernandez M, Nielsen M, Kristiansen TZ, Ohara O, Podtelejnikov AV, Roche S, Lodish HF, Mann M. Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases. Oncogene. 21: 8029-36. PMID 12439753 DOI: 10.1038/Sj.Onc.1205988 |
0.511 |
|
| 2002 |
Furstoss O, Manes G, Roche S. Cyclin E and cyclin A are likely targets of Src for PDGF-induced DNA synthesis in fibroblasts. Febs Letters. 526: 82-6. PMID 12208509 DOI: 10.1016/S0014-5793(02)03120-4 |
0.812 |
|
| 2002 |
Yart A, Roche S, Wetzker R, Laffargue M, Tonks N, Mayeux P, Chap H, Raynal P. A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid. The Journal of Biological Chemistry. 277: 21167-78. PMID 11916960 DOI: 10.1074/Jbc.M110411200 |
0.495 |
|
| 2002 |
Furstoss O, Dorey K, Simon V, Barilà D, Superti-Furga G, Roche S. c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis. The Embo Journal. 21: 514-24. PMID 11847100 DOI: 10.1093/Emboj/21.4.514 |
0.812 |
|
| 2001 |
Lara-Pezzi E, Roche S, Andrisani OM, Sánchez-Madrid F, López-Cabrera M. The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner Oncogene. 20: 3323-3331. PMID 11423982 DOI: 10.1038/Sj.Onc.1204451 |
0.422 |
|
| 2001 |
Bony C, Roche S, Shuichi U, Sasaki T, Crackower MA, Penninger J, Mano H, Pucéat M. A specific role of phosphatidylinositol 3-kinase gamma. A regulation of autonomic Ca(2)+ oscillations in cardiac cells. The Journal of Cell Biology. 152: 717-28. PMID 11266463 DOI: 10.1083/Jcb.152.4.717 |
0.496 |
|
| 2001 |
Yart A, Laffargue M, Mayeux P, Chretien S, Peres C, Tonks N, Roche S, Payrastre B, Chap H, Raynal P. A Critical Role for Phosphoinositide 3-Kinase Upstream of Gab1 and SHP2 in the Activation of Ras and Mitogen-activated Protein Kinases by Epidermal Growth Factor Journal of Biological Chemistry. 276: 8856-8864. PMID 11134009 DOI: 10.1074/Jbc.M006966200 |
0.538 |
|
| 2000 |
Bénistant C, Chapuis H, Roche S. A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells. Oncogene. 19: 5083-90. PMID 11042696 DOI: 10.1038/Sj.Onc.1203871 |
0.486 |
|
| 2000 |
Pandey A, Fernandez MM, Steen H, Blagoev B, Nielsen MM, Roche S, Mann M, Lodish HF. Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways. The Journal of Biological Chemistry. 275: 38633-9. PMID 10993906 DOI: 10.1074/Jbc.M007849200 |
0.511 |
|
| 2000 |
Bénistant C, Chapuis H, Mottet N, Noletti J, Crapez E, Bali JP, Roche S. Deregulation of the cytoplasmic tyrosine kinase cSrc in the absence of a truncating mutation at codon 531 in human bladder carcinoma. Biochemical and Biophysical Research Communications. 273: 425-30. PMID 10873622 DOI: 10.1006/Bbrc.2000.2948 |
0.534 |
|
| 2000 |
Manes G, Bello P, Roche S. Slap negatively regulates Src mitogenic function but does not revert Src-induced cell morphology changes. Molecular and Cellular Biology. 20: 3396-406. PMID 10779329 DOI: 10.1128/Mcb.20.10.3396-3406.2000 |
0.532 |
|
| 2000 |
Laffargue M, Raynal P, Yart A, Peres C, Wetzker R, Roche S, Payrastre B, Chap H. An epidermal growth factor receptor/Gab1 signaling pathway is required for activation of phosphoinositide 3-kinase by lysophosphatidic acid. The Journal of Biological Chemistry. 274: 32835-41. PMID 10551845 DOI: 10.1074/Jbc.274.46.32835 |
0.563 |
|
| 2000 |
Desai A, Holleran EA, Roche S, Servant G, Weiner O, Aasland R, Weinzierl RO, Ponnambalam V, Slesinger PA, Pfaff M, Schuldt A, Kudoh T, Sclafani RA. Cell biology Current Opinion in Cell Biology. 12: 265-275. DOI: 10.1016/S0955-0674(00)00086-7 |
0.326 |
|
| 1999 |
DESAI A, HOLLERAN E, ROCHE S, AASLAND R, WEINZIERL R, IZAURRALDE E, MATTER K, SLESINGER P, PFAFF M, HUCKRIEDE N. Cell biologyPaper alert Current Opinion in Cell Biology. 11: 641-650. DOI: 10.1016/S0955-0674(99)00048-4 |
0.329 |
|
| 1998 |
Roche S, Downward J, Raynal P, Courtneidge SA. A function for phosphatidylinositol 3-kinase β (p85α-p110β) in fibroblasts during mitogenesis: Requirement for insulin- and lysophosphatidic acid-mediated signal transduction Molecular and Cellular Biology. 18: 7119-7129. PMID 9819398 DOI: 10.1128/Mcb.18.12.7119 |
0.544 |
|
| 1998 |
Roche S, Alonso G, Kazlauskas A, Dixit VM, Courtneidge SA, Pandey A. Src-like adaptor protein (Slap) is a negative regulator of mitogenesis. Current Biology : Cb. 8: 975-8. PMID 9742401 DOI: 10.1016/S0960-9822(98)70400-2 |
0.516 |
|
| 1998 |
Pucéat M, Roche S, Vassort G. Src family tyrosine kinase regulates intracellular pH in cardiomyocytes. The Journal of Cell Biology. 141: 1637-46. PMID 9647655 DOI: 10.1083/Jcb.141.7.1637 |
0.547 |
|
| 1997 |
Boyer B, Roche S, Denoyelle M, Thiery JP. Src and Ras are involved in separate pathways in epithelial cell scattering The Embo Journal. 16: 5904-5913. PMID 9312048 DOI: 10.1093/Emboj/16.19.5904 |
0.512 |
|
| 1997 |
Carroll DJ, Ramarao CS, Mehlmann LM, Roche S, Terasaki M, Jaffe LA. Calcium release at fertilization in starfish eggs is mediated by phospholipase Cgamma. The Journal of Cell Biology. 138: 1303-11. PMID 9298985 DOI: 10.1083/Jcb.138.6.1303 |
0.327 |
|
| 1997 |
Chedin M, Filhol O, Duminy C, Bolla M, Benistant C, Roche S, Chambaz EM, Cochet C. Characterization of two different cytoplasmic protein tyrosine kinases from human breast cancer. Carcinogenesis. 18: 1463-72. PMID 9276617 DOI: 10.1093/Carcin/18.8.1463 |
0.517 |
|
| 1996 |
Erpel T, Alonso G, Roche S, Courtneidge SA. The Src SH3 domain is required for DNA synthesis induced by platelet-derived growth factor and epidermal growth factor. The Journal of Biological Chemistry. 271: 16807-12. PMID 8663328 DOI: 10.1074/Jbc.271.28.16807 |
0.5 |
|
| 1996 |
Roche S, McGlade J, Jones M, Gish GD, Pawson T, Courtneidge SA. Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways. The Embo Journal. 15: 4940-4948. DOI: 10.1002/J.1460-2075.1996.Tb00874.X |
0.474 |
|
| 1995 |
Dornand J, Roche S, Michel F, Bali JP, Cabane S, Favero J, Magous R. Gastrin-CCK-B type receptors on human T lymphoblastoid Jurkat cells. The American Journal of Physiology. 268: G522-9. PMID 7900813 DOI: 10.1152/Ajpgi.1995.268.3.G522 |
0.301 |
|
| 1995 |
Roche S, Koegl M, Barone MV, Roussel MF, Courtneidge SA. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases Molecular and Cellular Biology. 15: 1102-1109. PMID 7823926 DOI: 10.1128/Mcb.15.2.1102 |
0.559 |
|
| 1995 |
Roche S, Fumagalli S, Courtneidge SA. Requirement for Src family protein tyrosine kinases in G2 for fibroblast cell division Science. 269: 1567-1569. PMID 7545311 DOI: 10.1126/Science.7545311 |
0.522 |
|
| 1994 |
Roche S, Koegl M, Courtneidge SA. The phosphatidylinositol 3-kinase α is required for DNA synthesis induced by some, but not all, growth factors Proceedings of the National Academy of Sciences of the United States of America. 91: 9185-9189. PMID 8090789 DOI: 10.1073/Pnas.91.19.9185 |
0.43 |
|
| 1994 |
Roche S, Dhand R, Waterfield MD, Courtneidge SA. The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen pp60(c-src) complexes Biochemical Journal. 301: 703-711. PMID 7519847 DOI: 10.1042/Bj3010703 |
0.48 |
|
| 1994 |
Dhand R, Hiles I, Panayotou G, Roche S, Fry M, Gout I, Totty N, Truong O, Vicendo P, Yonezawa K. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. The Embo Journal. 13: 522-533. DOI: 10.1002/J.1460-2075.1994.Tb06290.X |
0.481 |
|
| 1992 |
Roche S, Gusdinar T, Bali JP, Magous R. Relationship between inositol 1,4,5-trisphosphate mass level and [14C]aminopyrine uptake in gastrin-stimulated parietal cells. Molecular and Cellular Endocrinology. 77: 109-13. PMID 1815995 DOI: 10.1016/0303-7207(91)90064-Y |
0.307 |
|
| 1991 |
Roche S, Bali JP, Magous R. Involvement of a pertussis toxin-sensitive G protein in the action of gastrin on gastric parietal cells. Biochimica Et Biophysica Acta. 1055: 287-94. PMID 2124930 DOI: 10.1016/0167-4889(90)90045-F |
0.323 |
|
| 1991 |
Roche S, Bali JP, Galleyrand JC, Magous R. Characterization of a gastrin-type receptor on rabbit gastric parietal cells using L365,260 and L364,718. The American Journal of Physiology. 260: G182-8. PMID 1996638 DOI: 10.1152/Ajpgi.1991.260.2.G182 |
0.313 |
|
| 1991 |
Roche S, Gusdinar T, Bali J, Magous R. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa--I. Characterization by means of agonists. Biochemical Pharmacology. 42: 765-770. PMID 1714275 DOI: 10.1016/0006-2952(91)90034-3 |
0.306 |
|
| Show low-probability matches. |